| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/28/2009 | CA2705410A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062880A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/27/2009 | EP2061781A1 Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests |
| 05/27/2009 | EP2061773A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
| 05/27/2009 | EP2061768A2 Imidazole-4,5-dicarboxamide derivatives as jak-2 modulators |
| 05/27/2009 | EP2061761A1 Phenethylamide derivatives with kinase inhibitory activity |
| 05/27/2009 | EP1981874B1 Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 05/27/2009 | EP1922315B1 Preparation of an atorvastatin intermediate |
| 05/27/2009 | EP1749002B1 Pyrrole or imidazole amides for treating obesity |
| 05/27/2009 | EP1725544B1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| 05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1404666B1 4-substituted-picolinic acid amide derivatives useful as fungicides |
| 05/27/2009 | EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 05/27/2009 | EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors |
| 05/27/2009 | CN101443327A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
| 05/27/2009 | CN101443325A 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors |
| 05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 05/27/2009 | CN101440087A Phthalimide diglycidyl ether and preparation thereof |
| 05/27/2009 | CN101440082A Spirofluorene xanthene material, and preparation and use thereof |
| 05/27/2009 | CN101440078A 2,3-disubstituted benzofuran compounds and preparation thereof |
| 05/27/2009 | CN100491372C Substituted quinazoline derivatives as inhibitors of aurora kinases |
| 05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491363C C7 ester-substituted taxane |
| 05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491349C Antiviral agent |
| 05/27/2009 | CN100491323C Biaryloxymethylarenecarboxylic acids compound |
| 05/27/2009 | CN100491319C Process for producing epoxytriazole compound and intermediate therefor |
| 05/26/2009 | US7538233 Nitric oxide synthetase inhibitor; central nervous system disorders; multiple sclerosis; brain disorders; Parkinson's, Alzheimer's, Huntington's disease; amyotropic lateral sclerosis; antidepressants; schizophrenia |
| 05/26/2009 | US7538231 Tyrosine kinase inhibitors |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538138 Histamine-3 receptor antagonists; 4-(2-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-4-yl)benzonitrile; acute myocardial infarction, asthma, psychological disorders, gastrointestinal disorders, inflammation, jet lag, cancer, septic shock, Tourette's syndrome, neurodegenerative disorders |
| 05/26/2009 | US7538123 Indole derivative having piperidine ring |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | CA2396587C Pyridine ketone herbicide compositions |
| 05/26/2009 | CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists |
| 05/26/2009 | CA2376949C Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
| 05/26/2009 | CA2354774C Farnesyl protein transferase inhibitors |
| 05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
| 05/26/2009 | CA2291782C Production of mono and 1,7-bis-n-hydroxyalkyl-cyclene and lithium salt complexes |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009065131A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | WO2009064959A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | WO2009062874A2 Benzimidazole derivatives and their use as fxr agonists |
| 05/22/2009 | WO2009062289A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | WO2009010260A3 Condensed anthranilamide insecticides |
| 05/22/2009 | WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705562A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2704074A1 Novel methyl-benzimidazole derivatives |
| 05/21/2009 | US20090131681 Novel fused pyrazolyl compounds having an aminoalkylcarbonyl group |
| 05/21/2009 | US20090131680 Process for the preparation of olmesartan medoxomil |
| 05/21/2009 | US20090131667 Polymorphic forms of tadalafil |
| 05/21/2009 | US20090131492 Indole derivatives as CFTR modulators |
| 05/21/2009 | US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 |
| 05/21/2009 | US20090131463 Novel compounds |
| 05/21/2009 | US20090131452 4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methoxy-phenyl]- piperazine-1-carboxylic acid tert-butyl ester; nervous system disorders, particularly the central nervous system; obesity; cogition activators; Alzheimer's disease; drug abuse, drug dependence; schizophrenia; bioavailability; stability |
| 05/21/2009 | US20090131448 2-(Piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors |
| 05/21/2009 | US20090131417 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 05/21/2009 | US20090131416 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
| 05/20/2009 | EP2060570A2 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 05/20/2009 | EP2060566A1 Poly-substituted aryls |
| 05/20/2009 | EP2060565A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060260A1 Therapeutic agents useful for treating pain |
| 05/20/2009 | EP2059802A2 Methods for designing parp inhibitors and uses thereof |
| 05/20/2009 | EP2059516A1 Pyridine compounds for treating gpr119 related disorders |
| 05/20/2009 | EP2059502A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | CN101437803A Dibenzyl amine derivatives as CETP inhibitors |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/20/2009 | CN101437791A Crystalline form of atorvastatin calcium stable after storage |
| 05/20/2009 | CN101434600A Curcumin piperidone analog and use thereof in anti-tumor medicament |
| 05/20/2009 | CN101434585A Amide derivatives as GK activators |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/20/2009 | CN100488505C Use of Darifenacin and its salts |
| 05/20/2009 | CN100488504C Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 05/20/2009 | CN100488362C Herbicidal composition |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | US7534893 Imidazol-2-one compounds useful in the treatment of various disorders |
| 05/19/2009 | US7534805 Imidazole derivatives, their preparation and their use as medicaments |
| 05/19/2009 | US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |